, Volume 37, Issue 6, pp 579–584 | Cite as

The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo study

  • K. -F. Amthor
  • K. Dahl-Jørgensen
  • T. J. Berg
  • M. Skard Heier
  • L. Sandvik
  • Ø. Aagenæs
  • K. F. Hanssen


We have investigated the effect of long-term strict glycaemic control on peripheral and autonomic nerve function in 45 IDDM patients (age 18–42 years, diabetes duration 7–23 years) without clinical signs of neuropathy or other neurological disease. They were randomly assigned to treatment either with continuous insulin infusion, multiple injections (4–6 times daily), or conventional treatment (twice daily) for 4 years and followed prospectively for 8 years. Motor and sensory nerve conduction velocities were measured at the start and after 8 years. Autonomic nerve function tests were performed only once, after 8 years. A significant reduction of nerve conduction velocity was observed during 8 years in patients with mean HbA1 more than 10% (n=12, group mean 10.9%, range 10.1–13.2%) compared to patients with HbA1 less than 10% (n=33, group mean 9.0%, range 7.5–9.9%). Change of motor nerve conduction velocity in the peroneal nerve was: −4.8±4.9 (SD) vs −2.2±5.3 m/s (p<0.01). Change of motor nerve conduction velocity in the posterior tibial nerve was: −6.8±5.7 vs −3.9±5.1 m/s (p<0.05). No significant changes were observed in the ulnar nerve. Change of sensoric nerve conduction velocity in the sural nerve was: −8.9±8.0 vs −4.6±5.3 m/s (p<0.05). Multiple regression analysis showed that a change in HbA1 of 1% resulted in a 1.3 m/s change in nerve conduction velocity during 8 years. A significantly lowered heart-rate variation during deep breathing (p<0.05) and heart-rate response to standing (p<0.01) was found in patients with HbA1 more than 10% compared to patients with HbA1 less than 10%. This study confirms that the long-term lowering of blood glucose retards the deterioration in nerve conduction velocity observed in the diabetic nerve.

Key words

IDDM nerve conduction velocity neuropathy intensified insulin treatment 



Insulin-dependent diabetes mellitus


  1. 1.
    Brown MJ, Ashbury AK (1984) Diabetic neuropathy. Ann Neurol 15: 2–12PubMedGoogle Scholar
  2. 2.
    Brown MJ, Greene DA (1984) Diabetic neuropathy: pathophysiology and management. In: Asbury AK, Gilliat RW (eds) Peripheral nerve disorders. Butterworth & Co, London, pp 126–153Google Scholar
  3. 3.
    Thomas PK, Eliassen SG (1984) Diabetic neuropathy. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral neuropathy. 2nd edn. Saunders, Philadelphia, pp 1773–1810Google Scholar
  4. 4.
    Boulton AJM, Worth RC, Druru J et al. (1984) Genetic and metabolic studies in diabetic neuropathy. Diabetologia 26: 15–19CrossRefPubMedGoogle Scholar
  5. 5.
    Pirart J (1987) Diabetes mellitus and its degenerative complications: prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1: 168–188Google Scholar
  6. 6.
    Dahl-Jørgensen K, Bjøro T, Kjerulf P, Sandvik L, Bangstad HJ, Hanssen KF (1992) The effect of long term strict glycemic control on kidney function in insulin-dependent diabetes mellitus: seven year results from the Oslo Study. Kidney Int 41: 920–923PubMedGoogle Scholar
  7. 7.
    Brinchmann-Hansen O, Dahl-Jørgensen K, Sandvik L, Hanssen KF (1992) Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study. BMJ 304: 19–22PubMedGoogle Scholar
  8. 8.
    Hanssen KF, Bangstad H-J, Brinchmann-Hansen O, Dahl-Jørgensen K (1992) Blood glucose control and diabetic microvascular complications: long-term effects of near-normoglycaemia. Diabetic Med 9: 697–705PubMedGoogle Scholar
  9. 9.
    Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenqvist U (1991) Intensified conventional insulin-treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med 230: 101–108PubMedGoogle Scholar
  10. 10.
    Unger RH (1982) Meticulous control of diabetes: benefits, risks, and precautions. Diabetes 31: 479–483PubMedGoogle Scholar
  11. 11.
    Committee on Health Care Issues (1986) Does improved control of glycemia prevent or ameliorate diabetic polyneuropathy ? Ann Neurol 19: 288–290Google Scholar
  12. 12.
    Ward JD, Barnes CG, Fisher DJ, Baker RW (1971) Improvement in nerve conduction following treatment in newly diagnosed diabetics. Lancet 1:428–430CrossRefPubMedGoogle Scholar
  13. 13.
    Halar EM, Graf RJ, Halter JB, Brozovich FV, Soine TL (1982) Diabetic neuropathy: a clinical, laboratory and electrodiagnostic study. Arch Phys Med Rehabil 63: 298–303PubMedGoogle Scholar
  14. 14.
    Holman RR, Dornan TL, Mayon-White V et al. (1983) Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients: a two-year randomised prospective study. Lancet I: 204–208CrossRefGoogle Scholar
  15. 15.
    Fedele D, Negrin P, Cardone C et al. (1984) Influence of continuous subcutaneous insulin infusion (CSSI) treatment on diabetic somatic and autonomic neuropathy. J Endocrinol Invest 7: 623–628PubMedGoogle Scholar
  16. 16.
    Service FJ, Rizza RA, Daube JR, O'Brien PC, Dyck PJ (1985) Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy. Diabetologia 28: 722–727PubMedGoogle Scholar
  17. 17.
    Ehle AL, Raskin P (1986) Increased nerve conduction in diabetics after a year of improved glucoregulation. J Neurol Sci 74: 191–197CrossRefPubMedGoogle Scholar
  18. 18.
    Warnmoltz JR, Mendell JR, O'Dorisio TM, Cataland S (1987) Comparison of the effects of continuous subcutaneous infusion and split-mixed injection of insulin on nerve function type I diabetes mellitus. J Neurol Sci 82: 161–169CrossRefPubMedGoogle Scholar
  19. 19.
    Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF et al. (1986) Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. BMJ 293: 1195–1199PubMedGoogle Scholar
  20. 20.
    Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomie neuropathy. BMJ 285: 916–918PubMedGoogle Scholar
  21. 21.
    Veves A, Malik RA, Lye RH et al. (1991) The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy. Diabetic Med 8: 917–921PubMedGoogle Scholar
  22. 22.
    Mc Culloch DK, Campbell IW, Prescott RJ, Clarke BF (1980) Effect of alcohol intake on symptomatic peripheral neuropathy in diabetic men. Diabetes Care 3: 245–247PubMedGoogle Scholar
  23. 23.
    Dyck PJ, O'Brien PC (1989) Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy. Diabetes Care 12: 649–652PubMedGoogle Scholar
  24. 24.
    Young RR, Shahani BT (1978) Clinical value and limitation of F-wave determination. Muscle Nerve 1: 248–249PubMedGoogle Scholar
  25. 25.
    Behse F, Buchtal F, Carlsen F (1977) Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psych 40: 1072–1082PubMedGoogle Scholar
  26. 26.
    Dyck PJ, Sherman WR, Hallcher LM et al. (1980) Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 8: 590–596PubMedGoogle Scholar
  27. 27.
    Sima AAF, Brismar T (1985) Reversible diabetic nerve dysfunction: structural correlates to electrophysiological abnormalities. Ann Neurol 18: 21–29PubMedGoogle Scholar
  28. 28.
    Gregersen G (1986) Variation in motor conduction velocities produced by acute changes in the metabolic state in diabetic patients. Diabetologia 4: 273–277Google Scholar
  29. 29.
    Gregersen G (1967) Diabetic neuropathy: influence of age, sex, metabolic control, and duration of diabetes on motor conduction velocity. Neurology 17: 972–979PubMedGoogle Scholar
  30. 30.
    Boulton AJM, Drury J, Clarke B, Ward JD (1982) Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 5: 386–390PubMedGoogle Scholar
  31. 31.
    Pietri A, Ehle Al, Raskin P (1980) Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps. Diabetes 29: 668–671PubMedGoogle Scholar
  32. 32.
    Gambardella S, Napoli A, Spallone V et al. (1983) Influence of glucoregulation with continuous subcutaneous insulin infusion on nerve conduction velocity and beat to beat variation in diabetics. J Endocrinol Invest 6: 363–367PubMedGoogle Scholar
  33. 33.
    Warnmoltz JS, Mendell JR, O'Dorisio TM, Catland S (1981) Evaluation of portable infusion pump on peripheral nerve function in diabetes mellitus. Neurology 31: 129–133Google Scholar
  34. 34.
    Hamet P, Abarca G, Lopez D et al. (1982) Patient self-management of continuous subcutaneous insulin infusion. Diabetes Care 5: 485–491PubMedGoogle Scholar
  35. 35.
    Dahl-Jørgensen K (1987) Near normoglycemia and late diabetic complications. The Oslo study (Thesis). Acta Endocrinol [Suppl 284]Google Scholar
  36. 36.
    Reichard P, Nilsson B-Y, Rosenqvist U (1993) The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329: 304–309CrossRefPubMedGoogle Scholar
  37. 37.
    The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986Google Scholar
  38. 38.
    O'Brien IAD, O'Hare JP, Lewin IG, Corrall RJM (1986) The prevalence of autonomic neuropathy in insulin-dependent diabetes mellitus: a controlled study based on heart rate variability. Q J Med 61: 951–967Google Scholar
  39. 39.
    Jakobsen J, Christiansen JS, Kristoffersen J et al. (1988) Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in type I diabetes. Diabetes 37: 452–455PubMedGoogle Scholar
  40. 40.
    Malik RA, Newrick PG, Sharma AK et al. (1989) Microangiopathy in human diabetic neuropathy: relationship betweeen capillary abnormalities and the severity of neuropathy. Diabetologia 32: 92–102PubMedGoogle Scholar
  41. 41.
    Tesfaye S, Harris ND, Wilson RM, Ward JD (1992) Exerciseinduced conduction velocity increment: a marker of impaired peripheral nerve blood flow in diabetic neuropathy. Diabetologia 35: 155–159PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • K. -F. Amthor
    • 1
  • K. Dahl-Jørgensen
    • 2
  • T. J. Berg
    • 2
  • M. Skard Heier
    • 3
  • L. Sandvik
    • 4
  • Ø. Aagenæs
    • 2
  • K. F. Hanssen
    • 2
  1. 1.Department of NeurologyUllevål University HospitalOsloNorway
  2. 2.Aker Diabetes Research CenterAker University HospitalOsloNorway
  3. 3.Department of Clinical NeurophysiologyUllevål University HospitalOsloNorway
  4. 4.Medstat Ltd.OsloNorway

Personalised recommendations